🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

36,04 USD

Máx. histórico

41,81

55 días

Caída desde máximo

-13,80%

Rango 52 semanas

19,32 – 42,50

Variación hoy

+0,42%

Cierre anterior

35,89

Rango de hoy

35,56 – 36,78

Volumen hoy

6.686.435

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,48%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 13 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
25/09/2023 10,16 10,30 9,87 10,21 -1,16% 4,23% 2.211.400
22/09/2023 10,35 10,44 10,06 10,33 +1,08% 3,62% 4.722.800
21/09/2023 10,23 10,34 9,96 10,22 -1,06% 3,71% 3.302.500
20/09/2023 10,66 10,79 10,29 10,33 -4,35% 4,69% 3.147.400
19/09/2023 11,12 11,12 10,64 10,80 -2,88% 4,32% 3.107.900
18/09/2023 11,17 11,40 11,01 11,12 -1,51% 3,51% 3.432.700
15/09/2023 11,49 11,57 11,22 11,29 -1,74% 3,05% 22.401.000
14/09/2023 11,21 11,66 11,09 11,49 +2,96% 5,08% 2.092.100
13/09/2023 11,11 11,39 11,10 11,16 -0,53% 2,61% 2.555.400
12/09/2023 11,39 11,68 11,16 11,22 -2,52% 4,52% 3.642.900
11/09/2023 12,65 12,84 11,31 11,51 -8,65% 12,08% 6.629.100
08/09/2023 11,73 12,62 11,73 12,60 +7,69% 7,59% 10.030.000
07/09/2023 11,59 11,82 11,47 11,70 -0,76% 3,02% 3.026.100
06/09/2023 11,72 11,87 11,46 11,79 +0,34% 3,54% 2.246.900
05/09/2023 11,63 12,01 11,59 11,75 +0,60% 3,65% 3.887.400
01/09/2023 11,65 11,94 11,46 11,68 +0,95% 4,08% 3.710.500
31/08/2023 11,58 11,80 11,51 11,57 -0,09% 2,50% 3.799.400
30/08/2023 11,28 11,74 11,24 11,58 +2,93% 4,43% 2.613.700
29/08/2023 11,19 11,37 11,00 11,25 -0,35% 3,31% 1.755.700
28/08/2023 11,18 11,39 11,08 11,29 +1,35% 2,77% 2.219.900
25/08/2023 11,14 11,31 11,03 11,14 +0,27% 2,56% 1.706.500
24/08/2023 11,74 11,74 11,10 11,11 -5,12% 5,45% 2.247.000
23/08/2023 11,23 11,81 11,23 11,71 +5,02% 5,12% 4.385.300
22/08/2023 10,99 11,19 10,82 11,15 +1,73% 3,37% 2.890.200
21/08/2023 10,72 11,04 10,48 10,96 +0,83% 5,22% 4.985.600
18/08/2023 10,37 11,00 10,24 10,87 +3,82% 7,33% 3.958.200
17/08/2023 10,78 10,78 10,32 10,47 -3,15% 4,27% 4.506.900
16/08/2023 10,93 11,01 10,61 10,81 -1,46% 3,66% 4.854.900
15/08/2023 11,72 11,75 10,87 10,97 -6,32% 7,55% 4.461.900
14/08/2023 11,55 11,96 10,95 11,71 +1,21% 8,74% 3.652.500